JPWO2023204290A5 - - Google Patents
Info
- Publication number
- JPWO2023204290A5 JPWO2023204290A5 JP2024516323A JP2024516323A JPWO2023204290A5 JP WO2023204290 A5 JPWO2023204290 A5 JP WO2023204290A5 JP 2024516323 A JP2024516323 A JP 2024516323A JP 2024516323 A JP2024516323 A JP 2024516323A JP WO2023204290 A5 JPWO2023204290 A5 JP WO2023204290A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- nos
- chain variable
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022069831 | 2022-04-21 | ||
| PCT/JP2023/015857 WO2023204290A1 (ja) | 2022-04-21 | 2023-04-21 | 多重特異性ナノ粒子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023204290A1 JPWO2023204290A1 (cg-RX-API-DMAC7.html) | 2023-10-26 |
| JPWO2023204290A5 true JPWO2023204290A5 (cg-RX-API-DMAC7.html) | 2026-04-21 |
Family
ID=88419941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516323A Pending JPWO2023204290A1 (cg-RX-API-DMAC7.html) | 2022-04-21 | 2023-04-21 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2023204290A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023204290A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025059385A2 (en) * | 2023-09-14 | 2025-03-20 | Outpace Bio, Inc. | Anti-mesothelin chimeric antigen receptors and methods of use |
| WO2025167631A1 (zh) * | 2024-02-05 | 2025-08-14 | 北京三诺佳邑生物技术有限责任公司 | 特异性结合HBV pre-S1抗原、PD-L1抗原和CD3抗原的多特异性抗体及其应用 |
| WO2025242098A1 (zh) * | 2024-05-21 | 2025-11-27 | 康诺亚生物医药科技（成都）有限公司 | 针对ceacam5的抗体偶联药物及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2695991A1 (en) * | 2007-08-09 | 2009-02-12 | Daiichi Sankyo Company, Limited | Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| JP2016514676A (ja) * | 2013-03-15 | 2016-05-23 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 四価二重特異性抗体 |
| AU2016267166A1 (en) * | 2015-05-26 | 2017-12-07 | The General Hospital Corporation | Liposomal nanoconstructs and methods of making and using the same |
| WO2017165464A1 (en) * | 2016-03-21 | 2017-09-28 | Elstar Therapeutics, Inc. | Multispecific and multifunctional molecules and uses thereof |
| CN109498817B (zh) * | 2017-09-14 | 2026-03-06 | 上海交通大学 | 一种多细胞靶向脂质体 |
| WO2020070041A1 (en) * | 2018-10-01 | 2020-04-09 | F. Hoffmann-La Roche Ag | Bispecific antigen binding molecules comprising anti-fap clone 212 |
| WO2020071554A1 (ja) * | 2018-10-05 | 2020-04-09 | 北海道公立大学法人 札幌医科大学 | がん幹細胞特異的抗体 |
| US11976133B2 (en) * | 2020-01-31 | 2024-05-07 | Gensun Biopharma Inc. | Bispecific T cell engagers |
| MX2022013797A (es) * | 2020-05-08 | 2022-11-30 | Genmab As | Anticuerpos biespecificos contra cd3 y cd20. |
-
2023
- 2023-04-21 WO PCT/JP2023/015857 patent/WO2023204290A1/ja not_active Ceased
- 2023-04-21 JP JP2024516323A patent/JPWO2023204290A1/ja active Pending